TY  - GEN
N2  - This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.
DO  - 10.1007/978-3-319-18518-7
DO  - doi
AB  - This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike.
T1  - The future of HIV-1 therapeuticsresistance is futile? /
AU  - Torbett, Bruce E.,
AU  - Goodsell, David S.,
AU  - Richman, Douglas D.,
VL  - volume 389
CN  - RA643.8
ID  - 726740
KW  - Antiviral agents.
KW  - HIV infections
KW  - HIV antibodies.
SN  - 9783319185187
SN  - 3319185187
TI  - The future of HIV-1 therapeuticsresistance is futile? /
LK  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-18518-7
UR  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-18518-7
ER  -